PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2022
Reportstack, provider of premium market research reports announces the addition of PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2022 market report to its offering
Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning and cognitive deficits. WHO experts have estimated that roughly 24 million people are...
View full press release